Top Markets
Coin of the day
Kineta, Inc. Kineta, Inc.

Kineta, Inc.

KA
Rang in Aktien #34153
Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing... Kineta, Inc. is a clinical-stage biotechnology firm dedicated to developing immunotherapies, with a focus on oncology, neuroscience, and biodefense applications. The company engages in partnerships with a variety of entities, including private companies, government bodies, and other industry stakeholders. Among its significant strategic collaborators are Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Established in 2007, Kineta, Inc. was previously known as Lecura, Inc. and has its base of operations in Seattle, Washington.
Aktienkurs
$0.617
Zuletzt synchronisiert: 2024-10-14
Marktkapitalisierung
$6.13M
Veränderung (1 Tag)
0.49%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Kineta, Inc. (KA)

Kategorie

Kursverlauf für Kineta, Inc. (KA)
Höchster Schlusskurs: $0.60 am 2024-10-01

Niedrigster Schlusskurs: $660.46 am 2016-02-01
Kursverlauf der Aktie von Kineta, Inc. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 -85.01%
2023 -51.01%
2022 -54.76%
2021 -84.38%
2020 -61.46%
2019 -35.59%
2018 -2.25%
2017 -61.49%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE